Summer Sale

Up to 30% off — ends 7 Aug

ONLY00h00m00s

Get 30% Off

Up to 30% off — ends 7 Aug

ONLY00h00m00s

Wieslaw Bal

Narodowy Instytut Onkologii im Marii Skłodowskiej-Curie Państwowy Instytut Badawczy w Warszawie

Poland

This profile is automatically generated from trusted academic sources.

Google Scholar

ORCID

How do I reach out?

Meet Kite AI

Contact this professor

ORCID

Google Scholar

Research Interests

Pharmacotherapy

60%

Immunology

20%

Adjuvant Therapy

40%

Tumor Suppression

30%

Targeted Therapy

30%

Immunotherapy

30%

Cancer Therapy

30%

Ask ApplyKite AI

Start chatting

How can you help me contact this professor?

What are this professor's research interests?

How should I write an email to this professor?

Articles11

Melanoma genomics – will we go beyond BRAF in clinics?

Article Link

Year:

2024

Modern Approach to Melanoma Adjuvant Treatment with Anti-PD1 Immune Check Point Inhibitors or BRAF/MEK Targeted Therapy: Multicenter Real-World Report

Article Link

Year:

2023

Long-term clinical evidence of comparable efficacy and toxicity of nivolumab and pembrolizumab in advanced melanoma treatment

Article Link

Year:

2023

Long-Term Real-World Outcomes and Safety of Vemurafenib and Vemurafenib + Cobimetinib Therapy in Patients with BRAF-Mutated Melanoma.

Article Link

Year:

2023

Relevance of admission hyperglycaemia and diabetes mellitus to efficacy and safety of mechanical thrombectomy in stroke patients

Article Link

Year:

2022

Characteristics of Giant Nodular Melanomas in Special Locations: a Case Series and Review of the Literature

Article Link

Year:

2022

The role of enzalutamide in the treatment of prostate cancer from the perspective of Polish oncologists

Article Link

Year:

2022

Long Term Results and Prognostic Biomarkers for Anti-PD1 Immunotherapy Used after BRAFi/MEKi Combination in Advanced Cutaneous Melanoma Patients

Article Link

Year:

2022

Long-Term Outcomes of Targeted Therapy after First-Line Immunotherapy in BRAF-Mutated Advanced Cutaneous Melanoma Patients—Real-World Evidence

Article Link

Year:

2022

Clinical and Non-Clinical Determinants of the Effect of Mechanical Thrombectomy and Post-Stroke Functional Status of Patients in Short and Long-Term Follow-Up

Article Link

Year:

2021

NGS Analysis of Liquid Biopsy (LB) and Formalin-Fixed Paraffin-Embedded (FFPE) Melanoma Samples Using Oncomine™ Pan-Cancer Cell-Free Assay.

Article Link

Year:

2021

Collaborators10

Paweł Sobczuk

Medical University of Warsaw

POLAND

Anetta Lasek-Bal

Medical University of Silesia

POLAND

Rafal Suwinski

Chair/Professor

Maria Sklodowska-Curie National Research Institute of Oncology

POLAND

Kamil Drucis

Medical University of Gdansk

POLAND

Anna Czarnecka

Professor

Maria Sklodowska-Curie National Research Institute of Oncology

POLAND

Magdalena Olbryt

Maria Sklodowska-Curie National Research Institute of Oncology

POLAND

Wieslawa Widlak

Maria Sklodowska-Curie National Research Institute of Oncology

POLAND

Magdalena Rosińska

current position: Head of Department

Maria Sklodowska-Curie National Research Institute of Oncology

POLAND

Bozena Cybulska-Stopa

Chief

Wrocław University of Scince and Technology

POLAND

Przemyslaw Puz

POLAND

How do I reach out?

Meet Kite AI